Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
LightPath Technologies Inc is an electronic components business based in the US. LightPath Technologies shares (LPTH) are listed on the NASDAQ and all prices are listed in US Dollars. LightPath Technologies employs 353 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$2.03|
|52-week range||$1.79 - $5.45|
|50-day moving average||$2.12|
|200-day moving average||$2.36|
|Wall St. target price||$3.53|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.12|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-20)||1.50%|
|1 month (2021-09-27)||-13.98%|
|3 months (2021-07-27)||-8.56%|
|6 months (2021-04-27)||-25.37%|
|1 year (2020-10-27)||-16.12%|
|2 years (2019-10-25)||180.04%|
|3 years (2018-10-26)||11.54%|
|5 years (2016-10-27)||30.13%|
Valuing LightPath Technologies stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of LightPath Technologies's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
LightPath Technologies's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.7 million.
The EBITDA is a measure of a LightPath Technologies's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$38.5 million|
|Gross profit TTM||$13.4 million|
|Return on assets TTM||-2.24%|
|Return on equity TTM||-9.35%|
|Market capitalisation||$52.6 million|
TTM: trailing 12 months
There are currently 429,737 LightPath Technologies shares held short by investors – that's known as LightPath Technologies's "short interest". This figure is 60.5% down from 1.1 million last month.
There are a few different ways that this level of interest in shorting LightPath Technologies shares can be evaluated.
LightPath Technologies's "short interest ratio" (SIR) is the quantity of LightPath Technologies shares currently shorted divided by the average quantity of LightPath Technologies shares traded daily (recently around 228583.5106383). LightPath Technologies's SIR currently stands at 1.88. In other words for every 100,000 LightPath Technologies shares traded daily on the market, roughly 1880 shares are currently held short.
However LightPath Technologies's short interest can also be evaluated against the total number of LightPath Technologies shares, or, against the total number of tradable LightPath Technologies shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case LightPath Technologies's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 LightPath Technologies shares in existence, roughly 20 shares are currently held short) or 0.0161% of the tradable shares (for every 100,000 tradable LightPath Technologies shares, roughly 16 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against LightPath Technologies.
Find out more about how you can short LightPath Technologies stock.
We're not expecting LightPath Technologies to pay a dividend over the next 12 months.
LightPath Technologies's shares were split on a 1:8 basis on 3 March 2003. So if you had owned 8 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your LightPath Technologies shares – just the quantity. However, indirectly, the new 700% higher share price could have impacted the market appetite for LightPath Technologies shares which in turn could have impacted LightPath Technologies's share price.
Over the last 12 months, LightPath Technologies's shares have ranged in value from as little as $1.79 up to $5.45. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while LightPath Technologies's is 1.3534. This would suggest that LightPath Technologies's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
LightPath Technologies, Inc. designs, develops, manufactures, and distributes optical components and assemblies. The company offers precision molded glass aspheric optics, molded and diamond-turned infrared aspheric lenses, and other optical components used to produce products that manipulate light. Its products are used in defense products, medical devices, laser aided industrial tools, automotive safety applications, barcode scanners, optical data storage, hybrid fiber coax datacom, telecommunications, machine vision and sensors, and other industries. The company sells its products directly to customers in North America, Europe, and Asia, as well as through distributors and catalogs in the United States and internationally. LightPath Technologies, Inc. was founded in 1985 and is headquartered in Orlando, Florida.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.